These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19768921)

  • 21. Almanac 2011: Cardiac arrhythmias and pacing. The national society journals present selected research that has driven recent advances in clinical cardiology.
    Liew R
    Heart; 2011 Nov; 97(21):1734-43. PubMed ID: 21948960
    [No Abstract]   [Full Text] [Related]  

  • 22. Ventricular arrhythmia: role of the implantable cardioverter defibrillator and radiofrequency ablation in addition to drugs.
    Fischer A; Verma R; Gomes JA; Mehta D
    Mt Sinai J Med; 2002 Sep; 69(4):197-207. PubMed ID: 12357261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
    Tanner H; Hindricks G; Kottkamp H
    Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventricular arrhythmias: state of the art.
    Schleifer JW; Srivathsan K
    Cardiol Clin; 2013 Nov; 31(4):595-605, ix. PubMed ID: 24188223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial fibrillation and the expanding role of catheter ablation: do antiarrhythmic drugs have a future?
    Naccarelli GV; Gonzalez MD
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):203-9. PubMed ID: 18806600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The place of hybrid therapies with drugs to supplement nonpharmacological therapies in atrial fibrillation.
    Govindan M; Catanchin A; Camm AJ
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):210-21. PubMed ID: 18806601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proarrhythmias and antiarrhythmias: two sides of the same coin.
    Kowey PR; Yan GX
    Heart Rhythm; 2005 Sep; 2(9):957-9. PubMed ID: 16171750
    [No Abstract]   [Full Text] [Related]  

  • 28. [Epidemiology and therapy of atrial fibrillation].
    Capucci A; Aschieri D; Villani GQ
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized clinical trials: how long should they last?
    Wellens HJ
    Circulation; 2004 Jul; 110(2):107-8. PubMed ID: 15249514
    [No Abstract]   [Full Text] [Related]  

  • 30. The implantable defibrillator. From concept to clinical reality.
    Jordaens L
    Adv Cardiol; 1996; 38():1-168. PubMed ID: 8955754
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS.
    Dizon J; Chen K; Dizon S; Biviano A; Whang W; Ehlert F; Vazquez J; Nazif T; Garan H
    Europace; 2011 Jan; 13(1):77-81. PubMed ID: 21149513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of ventricular arrhythmias.
    Aronow WS
    Minerva Cardioangiol; 2010 Dec; 58(6):657-76. PubMed ID: 21135807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of catheter ablation for ventricular tachycardia in patients with ischemic heart disease.
    El-Damaty A; Sapp JL
    Curr Opin Cardiol; 2011 Jan; 26(1):30-9. PubMed ID: 21119512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and ventricular tachycardia.
    Chu AF; Zado E; Marchlinski FE
    Am J Cardiol; 2010 Sep; 106(5):720-2. PubMed ID: 20723652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catheter ablation for cardiac arrhythmias.
    Lickfett L; Calkins H
    Minerva Cardioangiol; 2002 Jun; 50(3):189-207. PubMed ID: 12107400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].
    Candinas R; Bauersfeld U
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1545-9. PubMed ID: 7939521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are implantable cardioverter-defibrillators better than conventional antiarrhythmic drugs for survivors of cardiac arrest?
    Zipes DP
    Circulation; 1995 Apr; 91(8):2115-7. PubMed ID: 7697837
    [No Abstract]   [Full Text] [Related]  

  • 38. Radiofrequency catheter ablation of the AV node to improve the function of an antitachycardia implantable defibrillator.
    Pitney MR; Davis MJ; May CD
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 1):1657-60. PubMed ID: 1279531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of antiarrhythmic drugs and implantable devices in controlling ventricular tachycardia and fibrillation.
    Rajawat YS; Dias D; Gerstenfeld EP; Dixit S; Shah B; Russo AM; Marchlinski FE
    Curr Cardiol Rep; 2002 Sep; 4(5):434-40. PubMed ID: 12169241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a role for antiarrhythmic drugs in patients with implantable defibrillators?
    Ho A; Assadi R; Pai SM; Pai RG
    Curr Cardiol Rep; 2006 Sep; 8(5):365-9. PubMed ID: 16956452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.